New York State Teachers Retirement System Sells 14,556 Shares of Agilent Technologies, Inc. (NYSE:A)

New York State Teachers Retirement System decreased its position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 5.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 237,560 shares of the medical research company's stock after selling 14,556 shares during the period. New York State Teachers Retirement System owned about 0.08% of Agilent Technologies worth $31,914,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of A. Massachusetts Financial Services Co. MA lifted its position in Agilent Technologies by 3.5% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 15,589,874 shares of the medical research company's stock worth $2,314,784,000 after buying an additional 525,214 shares in the last quarter. FMR LLC raised its stake in shares of Agilent Technologies by 62.2% in the third quarter. FMR LLC now owns 1,287,665 shares of the medical research company's stock worth $191,193,000 after acquiring an additional 493,947 shares during the last quarter. Worldquant Millennium Advisors LLC acquired a new position in shares of Agilent Technologies during the third quarter worth approximately $49,449,000. Van ECK Associates Corp increased its holdings in shares of Agilent Technologies by 8.7% in the fourth quarter. Van ECK Associates Corp now owns 3,235,263 shares of the medical research company's stock valued at $434,625,000 after purchasing an additional 258,358 shares in the last quarter. Finally, Jennison Associates LLC raised its position in Agilent Technologies by 63.3% in the 3rd quarter. Jennison Associates LLC now owns 586,439 shares of the medical research company's stock worth $87,075,000 after purchasing an additional 227,431 shares during the last quarter.

Insider Transactions at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,911 shares of the firm's stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the transaction, the chief executive officer now owns 39,652 shares of the company's stock, valued at approximately $5,947,800. This trade represents a 4.60 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Agilent Technologies Stock Up 1.5 %

Shares of NYSE:A traded up $2.01 during midday trading on Wednesday, reaching $137.21. 1,666,743 shares of the company were exchanged, compared to its average volume of 1,679,436. The firm has a market cap of $39.15 billion, a PE ratio of 31.04, a P/E/G ratio of 3.65 and a beta of 1.07. The company has a quick ratio of 1.58, a current ratio of 2.09 and a debt-to-equity ratio of 0.57. Agilent Technologies, Inc. has a fifty-two week low of $124.16 and a fifty-two week high of $155.35. The stock has a fifty day simple moving average of $141.21 and a two-hundred day simple moving average of $139.31.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings results on Monday, November 25th. The medical research company reported $1.46 EPS for the quarter, beating analysts' consensus estimates of $1.41 by $0.05. The company had revenue of $1.70 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a return on equity of 25.43% and a net margin of 19.80%. During the same period in the previous year, the company posted $1.38 earnings per share. The company's quarterly revenue was up .8% compared to the same quarter last year. As a group, sell-side analysts forecast that Agilent Technologies, Inc. will post 5.56 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the company. JPMorgan Chase & Co. lowered their target price on Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating for the company in a research note on Tuesday, November 26th. Bank of America lowered their price objective on Agilent Technologies from $153.00 to $150.00 and set a "neutral" rating for the company in a research report on Friday, December 13th. Sanford C. Bernstein cut their target price on shares of Agilent Technologies from $140.00 to $135.00 and set a "market perform" rating on the stock in a research report on Tuesday, November 26th. StockNews.com upgraded shares of Agilent Technologies from a "hold" rating to a "buy" rating in a research report on Tuesday, December 24th. Finally, Wells Fargo & Company cut their price objective on shares of Agilent Technologies from $157.00 to $155.00 and set an "overweight" rating on the stock in a report on Monday, December 9th. Seven research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $144.38.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.